Prestige Consumer Healthcare Inc (PBH) Price Targets From Analysts
Use the tables below to see what analysts covering Prestige Consumer Healthcare Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $59 | $46 | $52.75 | $49.9 | 5.71% |
The Trend in the Analyst Price Target
PBH's average price target has moved up $10 over the prior 167 days.
PBH reports an average of 12.23% for its upside potential over the past 52 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-04 | 4 | 59 | 46 | 52.75 | 50.00 | 5.5% |
| 2021-05-22 | 4 | 57 | 46 | 51.50 | 49.39 | 4.27% |
| 2021-05-15 | 4 | 57 | 46 | 51.50 | 48.50 | 6.19% |
| 2021-05-08 | 4 | 57 | 46 | 50.25 | 46.10 | 9% |
| 2021-04-25 | 4 | 57 | 39 | 47.75 | 44.81 | 6.56% |
| 2021-04-17 | 4 | 57 | 39 | 47.75 | 45.22 | 5.59% |
| 2021-04-10 | 4 | 57 | 39 | 47.75 | 43.75 | 9.14% |
| 2021-04-03 | 4 | 57 | 39 | 47.75 | 43.07 | 10.87% |
| 2021-03-20 | 4 | 57 | 39 | 47.75 | 45.83 | 4.19% |
| 2021-03-13 | 4 | 57 | 39 | 47.75 | 46.48 | 2.73% |
| 2021-02-01 | 4 | 48 | 37 | 42.75 | 40.89 | 4.55% |
| 2021-01-30 | 4 | 48 | 37 | 42.75 | 40.00 | 6.88% |
| 2021-01-23 | 4 | 48 | 37 | 42.75 | 38.08 | 12.26% |
| 2021-01-16 | 4 | 48 | 37 | 42.75 | 37.52 | 13.94% |
| 2021-01-09 | 4 | 48 | 37 | 42.75 | 37.11 | 15.2% |
| 2021-01-02 | 4 | 48 | 37 | 42.75 | 34.87 | 22.6% |
| 2020-12-26 | 4 | 48 | 37 | 42.75 | 34.90 | 22.49% |
| 2020-12-19 | 4 | 48 | 37 | 42.75 | 36.14 | 18.29% |
| 2020-12-09 | 4 | 48 | 37 | 42.75 | 37.56 | 13.82% |
| 2020-12-07 | 4 | 48 | 37 | 42.75 | 36.21 | 18.06% |
| 2020-11-05 | 4 | 48 | 37 | 42.75 | 33.68 | 26.93% |
| 2020-10-27 | 3 | 48 | 37 | 44.00 | 33.21 | 32.49% |
| 2020-08-06 | 4 | 48 | 43 | 45.75 | 40.79 | 12.16% |
| 2020-06-08 | 4 | 49 | 43 | 46.25 | 42.12 | 9.81% |
PBH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.64 | 2 | 1 | 4 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 43 weeks, PBH's average broker recommendation rating worsened by 0.43.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Prestige Consumer Healthcare Inc's upside potential (average analyst target price relative to current price) is greater than 8.93% of Pharmaceutical Products stocks.
- The average analyst price target of PBH is higher than 79.97% of Pharmaceutical Products stocks.
- Prestige Consumer Healthcare Inc's number of analysts covering the stock is higher than 20.19% of stocks in the mid market cap category.
- The variance in analysts' estimates of PBH is lower than 69.6% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, RUBY, OVID and IRWD are the three stocks most similar to Prestige Consumer Healthcare Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding PBH using the data that counts. Try POWR Ratings for free.